Korean J Vet Res.  2011 Jun;51(2):101-105.

Resistance of Cryptosporidium parvum oocysts following commercial bleach treatment

Affiliations
  • 1National Veterinary Research & Quarantine Service, Anyang 430-856, Korea.
  • 2College of Veterinary Medicine, Kangwon National University, Chuncheon 200-701, Korea. advs@kangwon.ac.kr
  • 3College of Veterinary Medicine, Chungnam National University, Daejeon 305-764, Korea.

Abstract

We investigate the resistance of Cryptosporidium (C.) parvum oocysts to commercial bleach treatment. The viability and infectivity of C. parvum oocysts suspended in 100, 50, 25, 12.5, 6.3 or 3.2% aqueous commercial bleach for 10, 30, 60, 120 or 180 min at room temperature were assessed by nucleic acid Syto-9 staining, histologic examination of ileum and infectivity to immunosuppressed neonatal C57BL/6N mice. Although the viability was decreased compared with normal oocysts, all oocysts in contact with serially diluted commercial bleach for 180 min were alive by nucleic acid dye Syto-9 staining. And, microscopic examination of ileum sections revealed developmental stages of C. parvum in all mice. The oocyst shedding patterns between mice infected with oocysts contacted with commercial bleach and normal control mice were not significantly different each other. Although commercial bleach is widely used as a bacterial and viral disinfectant, the present findings indicate that it is not an effective disinfectant for C. parvum oocysts under practical conditions. Authors conclude that, therefore, it is undesirable to recommend commercial bleach as a disinfectant for C. parvum oocysts.

Keyword

Cryptosporidium parvum; sodium hypochlorite

MeSH Terms

Animals
Cryptosporidium
Cryptosporidium parvum
Ileum
Mice
Oocysts
Organic Chemicals
Sodium Hypochlorite
Organic Chemicals
Sodium Hypochlorite
Full Text Links
  • KJVR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr